Diabetes Type Clinical Trials 2024
Here are the 6 most popular medical studies for diabetes type 2
Behavioral Intervention
Mindfulness-Based Stress Reduction for Diabetes
This trial will compare the effects of an online mindfulness-based stress reduction intervention to an active control stress management education on glucose control in adults with uncontrolled type 1 or type 2 diabetes.
Popular filter options for diabetes type 2 trials
Type 2 Diabetes Clinical Trials
View 99 Type 2 Diabetes medical studies.
Procedure
Metabolic Surgery for Type 2 Diabetes
This trial is testing whether or not a vertical sleeve gastrectomy, a type of weight loss surgery, can help improve Type 2 diabetes in youth by looking at changes in things like insulin resistance, glycemic control, beta-cell function, and cardiovascular health.
Continuous Glucose Monitoring for Diabetes
This trial is testing a new system to help manage blood sugar levels for hospitalized patients with diabetes. The system wirelessly transmits sugar levels from the patient's bedside to a monitor at the nursing station. The goal is to decrease hypoglycemia and improve clinical outcomes.
Behavioural Intervention
Medication Optimization Intervention for HIV/AIDS
This trial will compare the health outcomes of two groups of African-Americans with HIV who either receive medication optimization with access to their medical records or usual care without access to records.
T2D Clinical Trials
View 99 T2D medical studies.
Procedure
Metabolic Surgery for Type 2 Diabetes
This trial is testing whether or not a vertical sleeve gastrectomy, a type of weight loss surgery, can help improve Type 2 diabetes in youth by looking at changes in things like insulin resistance, glycemic control, beta-cell function, and cardiovascular health.
Continuous Glucose Monitoring for Diabetes
This trial is testing a new system to help manage blood sugar levels for hospitalized patients with diabetes. The system wirelessly transmits sugar levels from the patient's bedside to a monitor at the nursing station. The goal is to decrease hypoglycemia and improve clinical outcomes.
Behavioural Intervention
Medication Optimization Intervention for HIV/AIDS
This trial will compare the health outcomes of two groups of African-Americans with HIV who either receive medication optimization with access to their medical records or usual care without access to records.
Phase 3 Diabetes Type 2 Clinical Trials
View 99 phase 3 diabetes type 2 medical studies.
Glucagon-like peptide-1 receptor agonist
Semaglutide for Chronic Kidney Disease in Type 2 Diabetes
This trial is testing whether semaglutide can help slow down the progression of kidney disease in people with type 2 diabetes. Participants will be given either semaglutide or a placebo, and neither they nor the researchers will know who is receiving which. The study will last for 3-5 years.
GLP-1 Receptor Agonist
Oral Semaglutide for Type 2 Diabetes in Youth
This trial is testing a new diabetes medication, semaglutide, to see how well it works compared to a placebo. It will also test if semaglutide is safe for children and teenagers. Participants will take the medicine every morning on an empty stomach and have 12 clinic visits over the course of the 66-week study.
Glucagon-like peptide-1 receptor agonist
Semaglutide for Type 2 Diabetes with Chronic Kidney Disease
This trial is testing if semaglutide can help fight chronic kidney disease in people with type 2 diabetes. Participants will be randomly assigned to receive either semaglutide or placebo, and will be monitored for a year through clinic visits and phone calls. Blood and urine samples will be taken, and participants will also have MRI scans.
Diabetes Type 2 Clinical Trials With No Placebo
View 99 diabetes type 2 medical studies that do not have a placebo group.
Procedure
Metabolic Surgery for Type 2 Diabetes
This trial is testing whether or not a vertical sleeve gastrectomy, a type of weight loss surgery, can help improve Type 2 diabetes in youth by looking at changes in things like insulin resistance, glycemic control, beta-cell function, and cardiovascular health.
Behavioural Intervention
Medication Optimization Intervention for HIV/AIDS
This trial will compare the health outcomes of two groups of African-Americans with HIV who either receive medication optimization with access to their medical records or usual care without access to records.
View More Diabetes Type 2 Trials
See another 79 medical studies focused on diabetes type 2.
Frequently Asked Questions
Introduction to diabetes type 2
What are the top hospitals conducting diabetes type 2 research?
When it comes to advancing treatment options for individuals living with type 2 diabetes, several leading hospitals are making significant contributions through their clinical trials. In Los Angeles, the University of Southern California takes a proactive approach with three ongoing trials dedicated to type 2 diabetes, building upon their track record of six completed studies since initiating research in this area back in 2013. Meanwhile, on the opposite coast in Boston, the Joslin Diabetes Center is also at the forefront of innovative therapies. With two active trials and an impressive history of 33 previous studies focusing on type 2 diabetes since their first trial in 2001, they continue to push boundaries for improved management and care.
Additionally joining this effort are Novo Nordisk Investigational Sites located in La Mesa and Los Angeles respectively. These sites have been actively involved in conducting essential research by running two current clinical trials each related specifically to type 2 diabetes while having accomplished twelve past investigations starting as early as2003 and fifty-seven extensive explorations beginning from year2002 consecutively.In another location within San Diego lies yet another Novo Nordisk Investigational Site conducting similar pioneering endeavors; they currently maintain two ongoing tests concerning type- II-diabetes.With thirty-five prior projects undertaken relating especially towards managing this condition which initiated from year2006 itself.
These esteemed institutions demonstrate not only commitment but also collaboration towards finding more effective treatments for those affected by type 2 diabetes. By participating in these clinical trials, patients help pave the way for future breakthroughs that hold promise for millions living with this chronic disease worldwide
Which are the best cities for diabetes type 2 clinical trials?
When it comes to diabetes type 2 clinical trials, several cities across the United States are at the forefront of research and innovation. San Antonio, Texas emerges as a top destination with its eight ongoing trials investigating treatments like Empagliflozin, Mifepristone 300 mg, Semaglutide, and lifestyle interventions. Los Angeles, California follows closely behind with seven active studies focusing on therapies such as Mifepristone 300 mg and Peer Support Groups. Atlanta, Georgia; Austin, Texas; and Boston Massachusetts also contribute significantly to diabetes type 2 research through their respective clinical trials exploring various treatment options for improved management and understanding of this chronic condition.
Which are the top treatments for diabetes type 2 being explored in clinical trials?
Clinical trials are actively exploring potential treatments for type 2 diabetes, with two notable contenders in the spotlight. Semaglutide has emerged as a leading candidate, currently undergoing four active trials and accumulating a total of 58 trials dedicated to diabetes type 2 since its debut in 2017. Another innovative approach is the Community Health Navigator Program, which aims to provide support and guidance through three ongoing clinical trials. Introduced recently in 2021, this program shows promise as an alternative avenue for managing and treating type 2 diabetes. As research progresses, these developments offer hope for improving the lives of individuals living with this chronic condition.
What are the most recent clinical trials for diabetes type 2?
Recent clinical trials offer promising insights into the management of type 2 diabetes. The MANAGe-DM trial, currently in Phase 3, presents a potential breakthrough in the field. Another noteworthy study is Active, which has shown positive results in Phase 1 and Phase 4 for individuals with diabetes type 2. Additionally, there are two ongoing trials involving semaglutide and mifepristone that aim to evaluate their efficacy when combined with lifestyle interventions or used as standalone treatments for type 2 diabetes patients. These studies represent significant advancements toward improving treatment options and outcomes for individuals living with this condition.
What diabetes type 2 clinical trials were recently completed?
Several recent clinical trials have made significant strides in the field of diabetes type 2. In August 2022, Pfizer successfully completed a trial for PF-07081532, while Glyscend, Inc.'s trial investigating GLY-200 also concluded during the same month. Vanderbilt University Medical Center's study on L-Lysine came to an end in March 2022, along with Gan and Lee Pharmaceuticals' trial testing GZR-18. Other notable trials include Altimmune, Inc.'s completion of their study on ALT-801 in February 2022 and Sanofi's trial evaluating Insulin glargine/Lixisenatide in January 2022. These pioneering efforts by various organizations highlight the ongoing commitment to advancing treatments for patients living with diabetes type 2.